Abstract:The results of this study reveal that PQQ can bind to and stabilize MCM3, which competes with Nrf2 for binding to Keap1 and enhances Nrf2‐ARE signaling. PQQ‐induced Nrf2 activation in osteoblast‐lineage cells increases the cellular stress response and also transcriptionally activates Fbn1, thus reducing the production of Rankl and inhibiting osteoclastic bone resorption, and preventing natural aging‐related osteoporosis. In addition, PQQ‐mediated Nrf2 activation in osteoblasts‐lineage cells can inhibit DNA damage and cellular senescence and increase osteoblastic bone formation. These findings demonstrate the underlying mechanism of PQQ's strong antioxidant capacity and suggest that PQQ could be an ideal supplement for the treatment and prevention of aging‐related osteoporosis. Age‐related osteoporosis is associated with increased oxidative stress and cellular senescence. Pyrroloquinoline quinone (PQQ) is a water‐soluble vitamin‐like compound that has strong antioxidant capacity; however, the effect and underlying mechanism of PQQ on aging‐related osteoporosis remain unclear. The purpose of this study was to investigate whether dietary PQQ supplementation can prevent osteoporosis caused by natural aging, and the potential mechanism underlying PQQ antioxidant activity. Here, we found that when 6‐month‐old or 12‐month‐old wild‐type mice were supplemented with PQQ for 12 months or 6 months, respectively, PQQ could prevent age‐related osteoporosis in mice by inhibiting osteoclastic bone resorption and stimulating osteoblastic bone formation. Mechanistically, pharmmapper screening and molecular docking studies revealed that PQQ appears to bind to MCM3 and reduces its ubiquitination‐mediated degradation; stabilized MCM3 then competes with Nrf2 for binding to Keap1, thus activating Nrf2‐antioxidant response element (ARE) signaling. PQQ‐induced Nrf2 activation inhibited bone resorption through increasing stress response capacity and transcriptionally upregulating fibrillin‐1 (Fbn1), thus reducing Rankl production in osteoblast‐lineage cells and decreasing osteoclast activation; as well, bone formation was stimulated by inhibiting osteoblastic DNA damage and osteocyte senescence. Furthermore, Nrf2 knockout significantly blunted the inhibitory effects of PQQ on oxidative stress, on increased osteoclast activity and on the development of aging‐related osteoporosis. This study reveals the underlying mechanism of PQQ's strong antioxidant capacity and provides evidence for PQQ as a potential agent for clinical prevention and treatment of natural aging‐induced osteoporosis.

The mechanism of pyrroloquinoline quinone influencing the fracture healing process of estrogen-deficient mice by inhibiting oxidative stress

Pyrroloquinoline quinone alleviates natural aging‐related osteoporosis via a novel MCM3‐Keap1‐Nrf2 axis‐mediated stress response and Fbn1 upregulation

The Protective Effect of Piperine on Ovariectomy Induced Bone Loss in Female Mice and Its Enhancement Effect of Osteogenic Differentiation Via Wnt/β-catenin Signaling Pathway

Estrogen deficiency impedes fracture healing despite eliminating the excessive absorption of the posterior callus in a semi-fixed distal tibial fracture mouse model

Psoralen, a natural phytoestrogen, improves diaphyseal fracture healing in ovariectomized mice: A preliminary study

Mini-review: Functions and Action Mechanisms of PQQ in Osteoporosis and Neuro Injury

Dietary Isoquercetin Ameliorates Bone Loss via Restoration of the Gut Microbiota and Lipopolysaccharide-Triggered Inflammatory Status in Ovariectomy Mice

The Beneficial Effect of Praeruptorin C on Osteoporotic Bone in Ovariectomized Mice Via Suppression of Osteoclast Formation and Bone Resorption

Puerarin improves the bone micro-environment to inhibit OVX-induced osteoporosis via modulating SCFAs released by the gut microbiota and repairing intestinal mucosal integrity

Oral dehydroepiandrosterone supplementation enhances osteoporotic fracture healing in the OVX rats

Bone Marrow Ablation Demonstrates That Estrogen Plays an Important Role in Osteogenesis and Bone Turnover Via an Antioxidative Mechanism

PQQ Dietary Supplementation Prevents Alkylating Agent-Induced Ovarian Dysfunction in Mice

Deciphering the protective effect of Buzhong Yiqi Decoction on osteoporotic fracture through network pharmacology and experimental validation

Osteoporosis influence on fracture healing in ovariectomized rat: ultrastructural study

Pyrroloquinoline quinone promotes human mesenchymal stem cell-derived mitochondria to improve premature ovarian insufficiency in mice through the SIRT1/ATM/p53 pathway

Quercetin ameliorates bone loss in OVX rats by modulating the intestinal flora-SCFAs-inflammatory signaling axis

Puerarin alleviates osteoporosis in the ovariectomy-induced mice by suppressing osteoclastogenesis via inhibition of TRAF6/ROS-dependent MAPK/NF-κB signaling pathways

Protective Effect of Pyrroloquinoline Quinone on TNF-α-induced Mitochondrial Injury in Chondrocytes

Pyrroloquinoline-Quinone Suppresses Liver Fibrogenesis in Mice

Picein alleviates oxidative stress and promotes bone regeneration in osteoporotic bone defect by inhibiting ferroptosis via Nrf2/HO-1/GPX4 pathway

Quercetin Alleviates Nanoparticle-Induced Osteolysis Via Deactivating Pyroptosis